Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Amphastar Pharmaceuticals | 865.20 Mn | 694.06 Mn | 70.32 Mn | 56.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.74% |
| Dec 31, 2025 | 456.55% |
| Sep 30, 2025 | -47.98% |
| Jun 30, 2025 | -48.36% |
| Mar 31, 2025 | -40.09% |
| Dec 31, 2024 | -114.33% |
| Sep 30, 2024 | 13.73% |
| Jun 30, 2024 | 55.16% |
| Mar 31, 2024 | 50.45% |
| Dec 31, 2023 | 259.18% |
| Sep 30, 2023 | 86.40% |
| Jun 30, 2023 | 1,879.94% |
| Mar 31, 2023 | -29.85% |
| Dec 31, 2022 | -60.07% |
| Sep 30, 2022 | 364.65% |
| Jun 30, 2022 | -108.22% |
| Mar 31, 2022 | 165.61% |
| Dec 31, 2021 | 10.83% |
| Sep 30, 2021 | -445.56% |
| Jun 30, 2021 | 63.35% |